Yury Portnoy

Mr. Yury Portnoy


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2003 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
AFAlexander A. Firsov
Alexander A. Firsov
SVSergey N. Vostrov
Sergey N. Vostrov
ILIrene Y. Lubenko
Irene Y. Lubenko
KDKarl Drlica
Karl Drlica
YPYury Portnoy
Yury Portnoy
SZStephen H. Zinner
Stephen H. Zinner
To study the hypothesis of the mutant selection window (MSW) in a pharmacodynamic context, the susceptibility of a clinical isolate of methicillin-resistant Staphylococcus aureus exposed to moxifloxacin (MOX), gatifloxacin (GAT), levofloxacin (LEV), and ciprofloxacin (CIP) was tested daily by using an in vitro dynamic model that simulates human pharmacokinetics. A series of monoexponential pharmacokinetic profiles that mimic once-daily administration of MOX (half-life, 12 h), GAT (half-life, 7 h), and LEV (half-life, 6.8 h) and twice-daily administration of CIP (half-life, 4 h) provided peak concentrations ( C max ) that either equaled the MIC, fell between the MIC and the mutant prevention concentration (MPC) (i.e., within or “inside” the MSW), or exceeded the MPC. The respective ratios of the area under the curve (AUC) over a 24-h dosing interval (AUC 24 ) to the MIC varied from 13 to 244 h, and the starting inoculum was 10 8 CFU/ml (6 × 10 9 CFU per 60-ml central compartment). With all four quinolones, the greatest increases in MIC were observed at those AUC 24 /MIC values (from 24 to 62 h) that corresponded to quinolone concentrations within the MSW over most of the dosing interval (>20%). Less-pronounced increases in MIC were associated with the smallest simulated AUC 24 /MIC values (15 to 16 h) of GAT and CIP, whose C max exceeded the MICs. No such increases were observed with the smallest AUC 24 /MIC values (13 to 17 h) of MOX and LEV, whose C max were close to the MICs. Also, less pronounced but significant increases in MIC occurred at AUC 24 /MIC values (107 to 123 h) that correspond to quinolone concentrations partly overlapping the MIC-to-MPC range. With all four drugs, no change in MIC was seen at the highest AUC 24 /MIC values (201 to 244 h), where quinolone concentrations exceeded the MPC over most of the dosing interval. These “protective” AUC 24 /MIC ratios correspond to 66% of the usual clinical dose of MOX (400 mg), 190% of a 400-mg dose of GAT, 220% of a 500-mg dose of LEV, and 420% of two 500-mg doses of CIP. Thus, MOX may protect against resistance development at subtherapeutic doses, whereas GAT, LEV, and CIP provide similar effects only at doses that exceed their usual clinical doses. These data support the concept that resistant mutants are selectively enriched when antibiotic concentrations fall inside the MSW and suggest that in vitro dynamic models can be used to predict the relative abilities of quinolones to prevent mutant selection.

5 October 2006 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
AFAlexander A. Firsov
Alexander A. Firsov
MSMaria V. Smirnova
Maria V. Smirnova
ILIrene Yu. Lubenko
Irene Yu. Lubenko
SVSergey N. Vostrov
Sergey N. Vostrov
YPYury Portnoy
Yury Portnoy
SZStephen H. Zinner
Stephen H. Zinner
Objectives: To extend the mutant selection window (MSW) hypothesis to include antibiotics in addition to fluoroquinolones, the pharmacodynamics of daptomycin (DAP) and vancomycin (VAN) and their ability to prevent the selection of resistant Staphylococcus aureus were studied in an in vitro model that simulates antibiotic concentrations below the MIC, between the MIC and the mutant prevention concentration (MPC), and above the MPC. Methods: Two clinical isolates of S. aureus, S. aureus 866 (MICDAP 0.35, MICVAN 0.7, MPCDAP 1.1, MPCVAN 2.4 mg/L) and S. aureus 10 (MICDAP 1.1, MICVAN 1.3, MPCDAP 5.5, MPCVAN 11 mg/L), were exposed for five consecutive days to once-daily daptomycin (half-life 9 h) and twice-daily vancomycin (half-life 6 h) at the ratio of 24 h area under the concentration–time curve (AUC24) to MIC that varied over a 16- to 30-fold range. The cumulative antimicrobial effect was expressed by its intensity (IE). Changes in susceptibility and numbers of surviving organisms on agar plates containing 2× and 4× MIC of daptomycin or vancomycin were monitored daily. Results: The IE-log AUC24/MIC plots were bacterial strain- and antibiotic-independent. This allowed combination of data obtained with both antibiotics and both organisms. Based on the sigmoid relationship between IE and the AUC24/MIC (r2 = 0.9), the antistaphylococcal effect of the therapeutic doses of daptomycin (4 and 6 mg/kg) against a hypothetical S. aureus with MIC equal to the MIC90 (AUC24/MIC90 380 and 570 h, respectively) was predicted to be similar to the effect of two 1 g doses of vancomycin given at a 12 h interval (AUC24/MIC90 200 h). AUC24/MIC relationships of the final-to-initial MIC ratio and logarithm of the ratio of maximal-to-initial numbers of organisms resistant to 2× and 4× MIC of daptomycin or vancomycin were bell-shaped and bacterial strain- and antibiotic-independent. Based on these relationships, an AUC24/MIC ratio that protects against the selection of resistant mutants was predicted at ≥200 h. This protective value is less than the AUC24/MIC90s provided by the 4 mg/kg dose and considerably less than the 6 mg/kg dose of daptomycin, but it is close to the AUC24/MIC90 provided by two 1 g doses of vancomycin. Conclusions: These findings support the MSW hypothesis and suggest comparable antistaphylococcal effects of clinically achievable AUC24/MIC90s of daptomycin and vancomycin but slightly better prevention against the selection of resistant S. aureus by daptomycin.

16 June 2004 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
AFAlexander A. Firsov
Alexander A. Firsov
SVSergey N. Vostrov
Sergey N. Vostrov
ILIrene Yu. Lubenko
Irene Yu. Lubenko
YPYury Portnoy
Yury Portnoy
SZStephen H. Zinner
Stephen H. Zinner
Objective: To compare the kinetics of killing/regrowth of differentially susceptible clinical isolates of Staphylococcus aureus exposed to ABT492 and levofloxacin and to explore their relative abilities to prevent the selection of resistant mutants. Methods: Three clinical isolates of S. aureus—including two ciprofloxacin-susceptible S. aureus, 201 and 480—and a ciprofloxacin-resistant S. aureus 866, were exposed to clinically achievable ratios of area under the curve (AUC) to MIC in a dynamic model that simulated human pharmacokinetics of ABT492 (400 mg) and levofloxacin (500 mg) as a single dose. In addition, S. aureus 201 was exposed to single and multiple doses of ABT492 and levofloxacin (both once daily for 3 days) over wide ranges of 24 h AUC/MIC (AUC24/MIC) including clinically achievable AUC24/MIC ratios. Results: With each isolate, ABT492 at clinically achievable AUC/MICs produced greater anti-staphylococcal effects than levofloxacin. Areas between the control growth and the time–kill curves (ABBC in single dose simulations and the sum of ABBCs determined after the first, second and third dosing in multiple dose simulations—ABBC1+2+3) were higher with ABT492 than levofloxacin. Moreover, at comparable AUC/MICs and AUC24/MICs, the maximal reductions in the starting inoculum of ABT492-exposed S. aureus were more pronounced than with levofloxacin. Loss in susceptibility of S. aureus 201 exposed to ABT492 or levofloxacin depended on the simulated AUC24/MIC. Although the maximal increase in MIC (MICfinal) related to its initial value (MICinitial) was seen at a higher AUC24/MIC ratio of ABT492 (120 h) than levofloxacin (50 h), similar AUC24/MICs (240 and 200 h, respectively) were protective against the selection of resistant S. aureus. These threshold values are readily achievable with 400 mg ABT492 (AUC24/MIC 870 h) but not with 500 mg levofloxacin (AUC24/MIC 70 h). Conclusion: Overall, these findings predict greater efficacy of clinically achievable AUC/MIC (or AUC24/MIC) of ABT492 both in terms of the anti-staphylococcal effect and prevention of the selection of resistant mutants.

1 October 2013 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
AFAlexander A. Firsov
Alexander A. Firsov
ESElena Strukova
Elena Strukova
DSDarya S. Shlykova
Darya S. Shlykova
YPYury Portnoy
Yury Portnoy
VKVarvara K. Kozyreva
Varvara K. Kozyreva
SZStephen H. Zinner
Stephen H. Zinner
In light of the concept of the mutant selection window, i.e., the range between the MIC and the mutant prevention concentration (MPC), MPC-related pharmacokinetic indices should be more predictive of bacterial resistance than the respective MIC-related indices. However, experimental evidence of this hypothesis remains limited and contradictory. To examine the predictive power of the ratios of the area under the curve (AUC 24 ) to the MPC and the MIC, the selection of ciprofloxacin-resistant mutants of four Escherichia coli strains with different MPC/MIC ratios was studied. Each organism was exposed to twice-daily ciprofloxacin for 3 days at AUC 24 /MIC ratios that provide peak antibiotic concentrations close to the MIC, between the MIC and the MPC, and above the MPC. Resistant E. coli was intensively enriched at AUC 24 /MPCs from 1 to 10 h (AUC 24 /MIC from 60 to 360 h) but not at the lower or higher AUC 24 /MPC and AUC 24 /MIC ratios. AUC 24 /MPC and AUC 24 /MIC relationships of the areas under the time courses of ciprofloxacin-resistant E. coli (AUBC M ) were bell-shaped. A Gaussian-like function fits the AUBC M -AUC 24 /MPC and AUBC M -AUC 24 /MIC data combined for all organisms ( r 2 = 0.69 and 0.86, respectively). The predicted anti-mutant AUC 24 /MPC ratio was 58 ± 35 h, and the respective AUC 24 /MIC ratio was 1,080 ± 416 h. Although AUC 24 /MPC was less predictive of strain-independent E. coli resistance than AUC 24 /MIC, the established anti-mutant AUC 24 /MPC ratio was closer to values reported for Staphylococcus aureus (60 to 69 h) than the respective AUC 24 /MIC ratio (1,080 versus 200 to 240 h). This implies that AUC 24 /MPC might be a better interspecies predictor of bacterial resistance than AUC 24 /MIC.

1 February 2015 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
AFAlexander A. Firsov
Alexander A. Firsov
MGMaria Golikova
Maria Golikova
ESElena Strukova
Elena Strukova
YPYury Portnoy
Yury Portnoy
ARAndrey V. Romanov
Andrey V. Romanov
SZStephen H. Zinner
Stephen H. Zinner
Bacterial resistance studies using in vitro dynamic models are highly dependent on the starting inoculum that might or might not contain spontaneously resistant mutants (RMs). To delineate concentration-resistance relationships with linezolid-exposed Staphylococcus aureus, a mixed inoculum containing both susceptible cells and RMs was used. An RM selected after the 9th passage of the parent strain (MIC, 2 μg/ml) on antibiotic-containing media (RM9; MIC, 8 μg/ml) was chosen for the pharmacodynamic studies, because the mutant prevention concentration (MPC) of linezolid against the parent strain in the presence of RM9 at 102 (but not at 104) CFU/ml did not differ from the MPC value determined in the absence of the RMs. Five-day treatments with twice-daily linezolid doses were simulated at concentrations either between the MIC and MPC or above the MPC. S. aureus RMs (resistant to 2× and 4× MIC but not 8× and 16× MIC) were enriched at ratios of the 24-h area under the concentration-time curve (AUC24) to the MIC that provide linezolid concentrations between the MIC and MPC for 100% (AUC24/MIC, 60 h) and 86% (AUC24/MIC, 120 h) of the dosing interval. No such enrichment occurred when linezolid concentrations were above the MIC and below the MPC for a shorter time (37% of the dosing interval; AUC24/MIC, 240 h) or when concentrations were consistently above the MPC (AUC24/MIC, 480 h). These findings obtained using linezolid-susceptible staphylococci supplemented with RMs support the mutant selection window hypothesis. This method provides an option to delineate antibiotic concentration-resistance relationships with bacteria that exhibit low mutation frequencies.

1 November 1998 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
AFAlexander A. Firsov
Alexander A. Firsov
SVSergey N. Vostrov
Sergey N. Vostrov
ASAlexander A. Shevchenko
Alexander A. Shevchenko
YPYury Portnoy
Yury Portnoy
SZStephen H. Zinner
Stephen H. Zinner
Time-kill studies, even those performed with in vitro dynamic models, often do not provide definitive comparisons of different antimicrobial agents. Also, they do not allow determinations of equiefficient doses or predictions of area under the concentration-time curve (AUC)/MIC breakpoints that might be related to antimicrobial effects (AMEs). In the present study, a wide range of single doses of trovafloxacin (TR) and twice-daily doses of ciprofloxacin (CI) were mimicked in an in vitro dynamic model. The AMEs of TR and CI against gram-negative bacteria with similar susceptibilities to both drugs were related to AUC/MICs that varied over similar eight-fold ranges [from 54 to 432 and from 59 to 473 (μg · h/ml)/(μg/ml), respectively]. The observation periods were designed to include complete bacterial regrowth, and the AME was expressed by its intensity (the area between the control growth in the absence of antibiotics and the antibiotic-induced time-kill and regrowth curves up to the point where viable counts of regrowing bacteria equal those achieved in the absence of drug [ I E ]). In each experiment monoexponential pharmacokinetic profiles of TR and CI were simulated with half-lives of 9.2 and 4.0 h, respectively. Linear relationships between I E and log AUC/MIC were established for TR and CI against three bacteria: Escherichia coli (MIC of TR [MIC TR ] = 0.25 μg/ml; MIC of CI [MIC CI ] = 0.12 μg/ml), Pseudomonas aeruginosa (MIC TR = 0.3 μg/ml; MIC CI = 0.15 μg/ml), and Klebsiella pneumoniae (MIC TR = 0.25 μg/ml; MIC CI = 0.12 μg/ml). The slopes and intercepts of these relationships differed for TR and CI, and the I E -log AUC/MIC plots were not superimposed, although they were similar for all bacteria with a given antibiotic. By using the relationships between I E and log AUC/MIC, TR was more efficient than CI. The predicted value of the AUC/MIC breakpoint for TR [mean for all three bacteria, 63 (μg · h/ml)/(μg/ml)] was approximately twofold lower than that for CI. Based on the I E -log AUC/MIC relationships, the respective dose ( D )-response relationships were reconstructed. Like the I E -log AUC/MIC relationships, the I E -log D plots showed TR to be more efficient than CI. Single doses of TR that are as efficient as two 500-mg doses of CI (500 mg given every 12 h) were similar for the three strains (199, 226, and 203 mg). This study suggests that in vitro evaluation of the relationships between I E and AUC/MIC or D might be a reliable basis for comparing different fluoroquinolones and that the results of such comparative studies may be highly dependent on their experimental design and datum quantitation.